121 related articles for article (PubMed ID: 2680842)
1. [Bismuth aluminate in gastroenterology. Therapeutic effects in chronic erosive Campylobacter pylori-associated gastritis].
Stanescu A; Malfertheiner P; Mayer D; Baczako K; Ditschuneit H
Fortschr Med; 1989 Oct; 107(29):623-6. PubMed ID: 2680842
[TBL] [Abstract][Full Text] [Related]
2. [Bismuth subsalicylate treatment in chronic Campylobacter pylori-associated erosive gastritis].
Malfertheiner P; Stanescu A; Baczako K; Vanek E; Bode G; Ditschuneit H
Dtsch Med Wochenschr; 1988 Jun; 113(23):923-9. PubMed ID: 3378501
[TBL] [Abstract][Full Text] [Related]
3. [Efficacy of a bismuth combination preparation. Efficacy in the treatment of chronic active gastritis and non-ulcerous dyspepsia].
Malfertheiner P; Stanescu A; Baczako K; Mayer D; Ditschuneit H
Fortschr Med; 1990 Jul; 108(20):402-6. PubMed ID: 2202619
[TBL] [Abstract][Full Text] [Related]
4. Treatment of Campylobacter pylori gastritis: a pilot study using pirenzepine dihydrochloride (Gastrozepin) and three formulations of colloidal bismuth subcitrate (De-Nol).
Morris A; Brown P; Ali MR; Lane M; Palmer R
N Z Med J; 1988 Oct; 101(856 Pt 1):651-4. PubMed ID: 3054641
[TBL] [Abstract][Full Text] [Related]
5. Histological gastritis in duodenal ulcer: relationship to Campylobacter pylori and effect of ulcer therapy.
Dooley CP; McKenna D; Humphreys H; Bourke S; Keane CT; Sweeney E; O'Morain C
Am J Gastroenterol; 1988 Mar; 83(3):278-82. PubMed ID: 3344730
[TBL] [Abstract][Full Text] [Related]
6. Gastric antral erosions and Helicobacter pylori infection in cirrhotic patients: a pilot controlled study of oral bismuth vs ranitidine therapy.
Balzano A; Mosca S; Amitrano L; Di Blasi A; Piccirillo MM; Gigliotti T
Ital J Gastroenterol; 1991; 23(3):132-5. PubMed ID: 1742507
[TBL] [Abstract][Full Text] [Related]
7. [Chronic active surface-positive Campylobacter antrum gastritis-- morphological changes 1 year after treatment with bismuth].
Sorf M; Krislo V; Gogora M
Vnitr Lek; 1991; 37(9-10):768-71. PubMed ID: 1771809
[TBL] [Abstract][Full Text] [Related]
8. Treatment of Campylobacter pylori does not alter gastric acid secretion.
Montbriand JR; Appelman HD; Cotner EK; Nostrant TT; Elta GH
Am J Gastroenterol; 1989 Dec; 84(12):1513-6. PubMed ID: 2596452
[TBL] [Abstract][Full Text] [Related]
9. The effect of bismuth subsalicylate on the histologic gastritis seen with Campylobacter pylori: a placebo-controlled, randomized study.
Lanza FL; Skoglund ML; Rack MF; Yardley JH
Am J Gastroenterol; 1989 Sep; 84(9):1060-4. PubMed ID: 2773899
[TBL] [Abstract][Full Text] [Related]
10. [Campylobacter pylori--relation to gastric pathology and the effect of bismuth therapy].
Huslarová A; Fric P; Jirásek A
Sb Lek; 1990; 92(11-12):349-53. PubMed ID: 2136429
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of Campylobacter pylori in esophagitis, gastritis, and duodenal disease.
Cheng EH; Bermanski P; Silversmith M; Valenstein P; Kawanishi H
Arch Intern Med; 1989 Jun; 149(6):1373-5. PubMed ID: 2730254
[TBL] [Abstract][Full Text] [Related]
12. Campylobacter pylori-associated gastritis: a double-blind placebo-controlled trial with amoxycillin.
Glupczynski Y; Burette A; Labbe M; Deprez C; De Reuck M; Deltenre M
Am J Gastroenterol; 1988 Apr; 83(4):365-72. PubMed ID: 3279757
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
Park KN; Hahm JS; Kim HJ
Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
[TBL] [Abstract][Full Text] [Related]
14. Campylobacter pylori and gastroduodenal disease: a prospective endoscopic study and comparison of diagnostic tests.
Chodos JE; Dworkin BM; Smith F; Van Horn K; Weiss L; Rosenthal WS
Am J Gastroenterol; 1988 Nov; 83(11):1226-30. PubMed ID: 3055942
[TBL] [Abstract][Full Text] [Related]
15. Rapid urease test in the management of Campylobacter pyloridis-associated gastritis.
Marshall BJ; Warren JR; Francis GJ; Langton SR; Goodwin CS; Blincow ED
Am J Gastroenterol; 1987 Mar; 82(3):200-10. PubMed ID: 3548326
[TBL] [Abstract][Full Text] [Related]
16. [The effect of colloidal bismuth and its combination with amoxicillin on the elimination of Helicobacter pylori in patients with a duodenal ulcer and chronic antral gastritis].
Piubello W; Aimo G; Soldinger E; Pistoso S; Raggi G; Superti G; Bonesi R; Vitali E
Recenti Prog Med; 1993 Jan; 84(1):40-4. PubMed ID: 8430249
[TBL] [Abstract][Full Text] [Related]
17. [Therapy of Campylobacter pylori infection].
Börsch G
Leber Magen Darm; 1988 Feb; 18(1):38-45. PubMed ID: 3280932
[TBL] [Abstract][Full Text] [Related]
18. Noninvasive tests as a substitute for histology in the diagnosis of Helicobacter pylori infection.
Hahn M; Fennerty MB; Corless CL; Magaret N; Lieberman DA; Faigel DO
Gastrointest Endosc; 2000 Jul; 52(1):20-6. PubMed ID: 10882957
[TBL] [Abstract][Full Text] [Related]
19. [Has Campylobacter pylori infection any clinical relevance? Methodologic, epidemiologic and clinical studies].
Döbrönte Z; Lakatos F; Brittig F; Löcsei Z; Bokor N; Stöckert A; Varga L
Orv Hetil; 1989 Nov; 130(48):2563-8. PubMed ID: 2689946
[TBL] [Abstract][Full Text] [Related]
20. The efficacy of two-week therapy with ranitidine bismuth citrate, amoxicillin and clarithromycin on Helicobacter pylori eradication in clarithromycinresistant and- sensitive cases.
Aydin A; Onder GF; Akarca US; Tekin F; Tunçyürek M; Musoğlu A
Turk J Gastroenterol; 2005 Dec; 16(4):203-6. PubMed ID: 16547848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
